SPY319.34+7.98 2.56%
DIA271.54+8.21 3.12%
IXIC9,814.08+198.27 2.06%

Harpoon Therapeutics Q1 EPS $(0.510) Up From $(0.920) YoY, Sales $3.297M Up From $1.063M YoY

Harpoon Therapeutics (NASDAQ:HARP) reported quarterly losses of $(0.510) per share. This is a 44.57 percent increase over losses of $(0.920) per share from the same period last year. The company reported $3.297 million

Benzinga · 05/06/2020 20:26

Harpoon Therapeutics (NASDAQ:HARP) reported quarterly losses of $(0.510) per share. This is a 44.57 percent increase over losses of $(0.920) per share from the same period last year. The company reported $3.297 million in sales this quarter. This is a 210.16 percent increase over sales of $1.063 million the same period last year.